Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Incyte

Corporate venture profile

Parent IncyteHQ Wilmington, United States

This profile covers the startup investments made by Incyte, a pharmaceutical and biotech company. It is based in Wilmington, United States. Sectors it names: biotech and life sciences, artificial intelligence.

Every figure links to its source

Where it invests

Geography

Investment regionsS1

Key facts

FactValueStatusSource
Parent companyIncyte (NASDAQ: INCY)Single sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
HeadquartersWilmington, United StatesSingle sourceS3
Capital sourceParent company onlySingle sourceS1

About Incyte

ItemDetailSource
Listed asNASDAQ: INCYS1
HeadquartersUnited StatesS1

History

  1. USD 40M equity investment with USD 80M upfront (May)S1

Portfolio

Portfolio companies named in public sources: Genesis Therapeutics, Prelude Therapeutics.S1

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Fierce BiotechPress
  2. S2Nasdaq: Incyte signs exclusive option deal for Prelude JAK2V617F inhibitor programPress
  3. S3SEC EDGAR submissions: Incyte business addressFiling

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Incyte or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.